M3 Advisory Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
M3 Advisory Group's XBI Position: Q1 2026 in Review
M3 Advisory Group held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 2,071 shares worth $265K. The position accounts for 0.16% of the portfolio, ranked #111.
M3 Advisory Group first reported a position in XBI in Q3 2025 and has held it in 3 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- M3 Advisory Group held 2,071 shares of State Street SPDR S&P Biotech ETF worth $265K as of Q1 2026.
- M3 Advisory Group left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
- State Street SPDR S&P Biotech ETF made up 0.16% of M3 Advisory Group's portfolio in Q1 2026, its #111 holding.
- M3 Advisory Group first reported a position in State Street SPDR S&P Biotech ETF in Q3 2025 and has held it in 3 quarters since.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on M3 Advisory Group's 13F filing for Q1 2026, filed 22 Apr 2026.